Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for PATZ1_KLF4
Z-value: 1.66
Motif logo
Transcription factors associated with PATZ1_KLF4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PATZ1
|
ENSG00000100105.18 | PATZ1 |
|
KLF4
|
ENSG00000136826.15 | KLF4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| KLF4 | hg38_v1_chr9_-_107489754_107489776 | 0.54 | 1.5e-17 | Click! |
| PATZ1 | hg38_v1_chr22_-_31345770_31345785 | 0.30 | 5.8e-06 | Click! |
Activity profile of PATZ1_KLF4 motif
Sorted Z-values of PATZ1_KLF4 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of PATZ1_KLF4
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 19.0 | 57.0 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 16.9 | 101.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 16.0 | 47.9 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 14.7 | 59.0 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 14.1 | 14.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 13.7 | 68.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 13.2 | 39.6 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 12.4 | 37.2 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 11.9 | 47.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 11.0 | 44.0 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 11.0 | 32.9 | GO:1900161 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 10.5 | 31.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 10.1 | 40.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 10.0 | 40.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 9.1 | 36.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 8.8 | 26.4 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 8.7 | 8.7 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 8.2 | 24.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 7.9 | 23.6 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 7.8 | 7.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 7.8 | 23.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 7.7 | 23.2 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 7.7 | 76.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 7.3 | 22.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 7.3 | 22.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 7.1 | 42.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 7.0 | 20.9 | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 6.9 | 27.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 6.6 | 6.6 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 6.6 | 79.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 6.5 | 19.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 6.4 | 19.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 6.4 | 51.2 | GO:0044351 | macropinocytosis(GO:0044351) |
| 6.4 | 19.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 6.4 | 25.5 | GO:0052031 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 6.3 | 25.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 6.2 | 49.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 6.2 | 55.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 6.1 | 18.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 6.0 | 36.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 5.9 | 17.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 5.9 | 17.7 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 5.9 | 17.6 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 5.8 | 5.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 5.8 | 23.2 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 5.8 | 5.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 5.7 | 23.0 | GO:0019086 | late viral transcription(GO:0019086) |
| 5.7 | 22.9 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 5.7 | 5.7 | GO:0033151 | V(D)J recombination(GO:0033151) |
| 5.6 | 22.6 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 5.6 | 33.8 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 5.6 | 5.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 5.6 | 39.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 5.6 | 27.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 5.5 | 5.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 5.5 | 16.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 5.4 | 21.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 5.4 | 21.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 5.2 | 25.9 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 5.1 | 15.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 5.1 | 25.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 5.0 | 39.9 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 5.0 | 9.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 4.9 | 4.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 4.9 | 19.8 | GO:0072218 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 4.9 | 14.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 4.9 | 4.9 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 4.8 | 43.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 4.8 | 4.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 4.8 | 14.5 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 4.8 | 14.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 4.8 | 28.6 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 4.7 | 14.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 4.7 | 28.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
| 4.7 | 14.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 4.6 | 4.6 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 4.6 | 23.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 4.6 | 9.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 4.6 | 4.6 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 4.6 | 22.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 4.6 | 13.7 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 4.6 | 18.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 4.5 | 9.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 4.5 | 27.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 4.5 | 13.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 4.5 | 54.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 4.5 | 4.5 | GO:0001743 | optic placode formation(GO:0001743) |
| 4.5 | 9.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 4.5 | 13.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 4.5 | 22.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 4.4 | 35.4 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 4.4 | 4.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 4.3 | 17.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 4.3 | 4.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 4.2 | 29.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 4.2 | 12.6 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 4.2 | 8.3 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 4.2 | 12.5 | GO:0009386 | translational attenuation(GO:0009386) |
| 4.1 | 12.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 4.1 | 37.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 4.1 | 16.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 4.1 | 16.4 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 4.1 | 12.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 4.1 | 16.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 4.1 | 44.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 4.0 | 8.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 4.0 | 43.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 4.0 | 75.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 3.9 | 23.7 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 3.9 | 23.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 3.9 | 11.8 | GO:0036047 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 3.9 | 15.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 3.9 | 27.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 3.9 | 11.7 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 3.9 | 15.5 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 3.9 | 3.9 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 3.9 | 11.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 3.9 | 15.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 3.8 | 15.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 3.8 | 19.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 3.8 | 49.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 3.8 | 11.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 3.8 | 15.2 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 3.8 | 15.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 3.8 | 11.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 3.8 | 22.6 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 3.8 | 15.0 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 3.8 | 11.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 3.7 | 7.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 3.7 | 11.2 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 3.7 | 11.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 3.7 | 26.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 3.7 | 37.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 3.7 | 11.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 3.7 | 14.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 3.7 | 7.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.7 | 14.7 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 3.7 | 14.6 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 3.6 | 10.9 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 3.6 | 18.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 3.6 | 21.6 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 3.6 | 39.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 3.6 | 10.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 3.5 | 14.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 3.5 | 14.0 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 3.5 | 14.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 3.5 | 17.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 3.5 | 3.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 3.5 | 10.4 | GO:0009726 | detection of hormone stimulus(GO:0009720) detection of endogenous stimulus(GO:0009726) |
| 3.4 | 27.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 3.4 | 3.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 3.4 | 10.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 3.4 | 10.2 | GO:0001812 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
| 3.4 | 13.6 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 3.4 | 13.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 3.4 | 23.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 3.4 | 13.4 | GO:0035627 | ceramide transport(GO:0035627) |
| 3.4 | 10.1 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 3.4 | 20.1 | GO:0016926 | protein desumoylation(GO:0016926) |
| 3.3 | 10.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 3.3 | 20.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 3.3 | 13.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 3.3 | 46.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 3.3 | 3.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 3.3 | 6.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 3.3 | 16.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 3.3 | 9.9 | GO:0036292 | DNA rewinding(GO:0036292) |
| 3.3 | 29.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 3.3 | 26.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 3.2 | 13.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 3.2 | 13.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 3.2 | 3.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 3.2 | 12.9 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 3.2 | 9.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 3.2 | 12.9 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 3.2 | 22.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 3.2 | 12.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 3.2 | 9.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 3.2 | 96.0 | GO:0097503 | sialylation(GO:0097503) |
| 3.2 | 6.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 3.2 | 6.4 | GO:0070295 | renal water absorption(GO:0070295) |
| 3.2 | 22.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 3.2 | 54.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 3.2 | 15.9 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 3.2 | 3.2 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 3.2 | 6.3 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 3.2 | 9.5 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 3.2 | 15.8 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 3.2 | 3.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 3.2 | 3.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 3.1 | 9.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 3.1 | 6.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 3.1 | 15.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 3.1 | 3.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 3.1 | 12.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 3.1 | 3.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 3.1 | 15.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 3.1 | 3.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 3.1 | 3.1 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
| 3.0 | 9.1 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 3.0 | 6.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 3.0 | 6.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 3.0 | 18.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 3.0 | 11.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 3.0 | 86.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 3.0 | 11.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 3.0 | 8.9 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
| 2.9 | 5.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 2.9 | 14.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 2.9 | 8.7 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 2.9 | 20.2 | GO:0046618 | drug export(GO:0046618) |
| 2.9 | 17.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 2.9 | 14.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.9 | 14.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 2.9 | 11.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 2.9 | 34.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 2.9 | 8.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 2.9 | 11.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 2.8 | 8.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 2.8 | 17.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.8 | 8.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 2.8 | 19.6 | GO:0045007 | depurination(GO:0045007) |
| 2.8 | 195.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 2.8 | 11.2 | GO:0048627 | myoblast development(GO:0048627) |
| 2.8 | 22.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 2.8 | 5.6 | GO:0007172 | signal complex assembly(GO:0007172) |
| 2.8 | 8.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 2.8 | 5.5 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 2.8 | 8.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 2.8 | 8.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 2.8 | 22.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 2.8 | 19.4 | GO:0070166 | enamel mineralization(GO:0070166) |
| 2.8 | 2.8 | GO:0007620 | copulation(GO:0007620) |
| 2.8 | 8.3 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 2.8 | 24.8 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 2.7 | 19.2 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 2.7 | 2.7 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 2.7 | 5.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 2.7 | 10.9 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 2.7 | 16.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 2.7 | 21.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 2.7 | 57.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 2.7 | 8.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 2.7 | 8.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 2.7 | 2.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 2.7 | 5.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
| 2.7 | 2.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 2.7 | 37.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 2.6 | 13.2 | GO:0035624 | receptor transactivation(GO:0035624) |
| 2.6 | 31.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 2.6 | 2.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 2.6 | 28.9 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 2.6 | 68.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 2.6 | 5.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 2.6 | 2.6 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 2.6 | 10.5 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 2.6 | 28.7 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 2.6 | 10.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 2.6 | 10.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 2.6 | 7.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 2.6 | 2.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 2.6 | 33.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 2.5 | 15.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 2.5 | 15.3 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 2.5 | 63.3 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 2.5 | 45.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 2.5 | 5.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 2.5 | 2.5 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 2.5 | 73.0 | GO:0071800 | podosome assembly(GO:0071800) |
| 2.5 | 7.5 | GO:0060032 | notochord regression(GO:0060032) |
| 2.5 | 7.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 2.5 | 7.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 2.5 | 10.0 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 2.5 | 10.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 2.5 | 84.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 2.5 | 7.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 2.5 | 9.9 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.5 | 9.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 2.5 | 7.4 | GO:0043416 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 2.5 | 2.5 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
| 2.5 | 14.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 2.5 | 19.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 2.4 | 12.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 2.4 | 7.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 2.4 | 4.9 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 2.4 | 9.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 2.4 | 24.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.4 | 9.7 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 2.4 | 9.7 | GO:0032252 | secretory granule localization(GO:0032252) |
| 2.4 | 41.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 2.4 | 33.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 2.4 | 7.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 2.4 | 9.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 2.4 | 9.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 2.4 | 2.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 2.4 | 2.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 2.4 | 40.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 2.4 | 11.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 2.4 | 14.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 2.4 | 18.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 2.4 | 4.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 2.3 | 37.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 2.3 | 11.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 2.3 | 9.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 2.3 | 9.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 2.3 | 9.2 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 2.3 | 52.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 2.3 | 18.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 2.3 | 36.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 2.3 | 6.8 | GO:2000798 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 2.3 | 11.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 2.3 | 18.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.3 | 2.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 2.3 | 11.3 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 2.3 | 6.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 2.3 | 11.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 2.3 | 9.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 2.3 | 11.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 2.3 | 31.5 | GO:0045730 | respiratory burst(GO:0045730) |
| 2.2 | 11.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 2.2 | 31.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 2.2 | 15.6 | GO:0015811 | L-cystine transport(GO:0015811) |
| 2.2 | 2.2 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 2.2 | 2.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 2.2 | 26.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 2.2 | 6.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 2.2 | 13.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 2.2 | 11.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 2.2 | 19.8 | GO:0072553 | terminal button organization(GO:0072553) |
| 2.2 | 2.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 2.2 | 6.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 2.2 | 24.1 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 2.2 | 15.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 2.2 | 21.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 2.2 | 6.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 2.2 | 10.9 | GO:0090135 | actin filament branching(GO:0090135) |
| 2.2 | 19.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 2.2 | 21.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 2.2 | 4.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 2.2 | 15.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 2.1 | 19.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.1 | 6.4 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
| 2.1 | 4.3 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 2.1 | 29.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 2.1 | 17.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 2.1 | 12.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 2.1 | 8.5 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 2.1 | 17.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 2.1 | 12.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 2.1 | 6.3 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 2.1 | 6.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 2.1 | 6.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 2.1 | 14.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 2.1 | 4.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 2.1 | 4.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 2.1 | 6.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.1 | 14.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 2.1 | 4.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 2.1 | 14.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 2.1 | 6.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 2.1 | 53.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 2.1 | 18.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 2.1 | 26.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 2.0 | 6.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 2.0 | 8.2 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 2.0 | 16.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 2.0 | 8.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 2.0 | 2.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 2.0 | 14.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 2.0 | 6.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 2.0 | 8.1 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 2.0 | 16.2 | GO:0030091 | protein repair(GO:0030091) |
| 2.0 | 2.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 2.0 | 6.0 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 2.0 | 6.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 2.0 | 14.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 2.0 | 6.0 | GO:1904640 | response to methionine(GO:1904640) |
| 2.0 | 2.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 2.0 | 4.0 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 2.0 | 12.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 2.0 | 174.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 2.0 | 5.9 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 2.0 | 3.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 2.0 | 5.9 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
| 2.0 | 3.9 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) |
| 1.9 | 21.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 1.9 | 25.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 1.9 | 9.7 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 1.9 | 1.9 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.9 | 17.4 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 1.9 | 1.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.9 | 13.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 1.9 | 32.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 1.9 | 5.8 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 1.9 | 25.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.9 | 13.5 | GO:0060992 | response to fungicide(GO:0060992) |
| 1.9 | 21.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.9 | 1.9 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 1.9 | 3.8 | GO:0072535 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
| 1.9 | 7.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 1.9 | 11.3 | GO:0050893 | sensory processing(GO:0050893) |
| 1.9 | 5.7 | GO:0061010 | gall bladder development(GO:0061010) hepatic duct development(GO:0061011) |
| 1.9 | 5.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 1.9 | 18.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 1.9 | 3.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
| 1.9 | 9.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 1.9 | 1.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 1.9 | 1.9 | GO:0042116 | macrophage activation(GO:0042116) |
| 1.9 | 22.3 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.8 | 14.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 1.8 | 7.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.8 | 5.5 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 1.8 | 1.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 1.8 | 3.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 1.8 | 7.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 1.8 | 10.9 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 1.8 | 1.8 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 1.8 | 35.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 1.8 | 1.8 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 1.8 | 9.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 1.8 | 3.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 1.8 | 1.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.8 | 3.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 1.8 | 14.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 1.8 | 10.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.8 | 1.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 1.8 | 19.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 1.8 | 40.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 1.8 | 3.6 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.8 | 3.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 1.8 | 5.3 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.8 | 5.3 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 1.7 | 5.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.7 | 5.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 1.7 | 3.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 1.7 | 5.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.7 | 12.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 1.7 | 5.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.7 | 1.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.7 | 3.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 1.7 | 5.2 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
| 1.7 | 18.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 1.7 | 12.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.7 | 5.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.7 | 3.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.7 | 23.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 1.7 | 15.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 1.7 | 3.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 1.7 | 28.5 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 1.7 | 6.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 1.7 | 1.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 1.7 | 11.7 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 1.7 | 5.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 1.7 | 5.0 | GO:0001842 | neural fold formation(GO:0001842) |
| 1.7 | 14.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 1.7 | 5.0 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 1.7 | 3.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 1.7 | 13.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.6 | 4.9 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.6 | 4.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.6 | 1.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.6 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 1.6 | 6.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.6 | 6.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 1.6 | 11.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 1.6 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 1.6 | 3.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 1.6 | 45.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 1.6 | 1.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 1.6 | 4.8 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.6 | 3.2 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 1.6 | 1.6 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 1.6 | 3.2 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 1.6 | 4.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 1.6 | 4.8 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 1.6 | 4.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.6 | 6.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 1.6 | 4.8 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 1.6 | 9.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 1.6 | 4.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.6 | 15.8 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
| 1.6 | 6.3 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.6 | 1.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.6 | 12.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 1.6 | 7.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.6 | 3.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 1.6 | 3.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 1.6 | 10.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.6 | 12.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.6 | 3.1 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 1.6 | 4.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 1.6 | 4.7 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.6 | 1.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 1.6 | 20.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 1.6 | 6.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 1.5 | 10.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 1.5 | 29.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 1.5 | 3.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 1.5 | 1.5 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 1.5 | 15.4 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 1.5 | 1.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 1.5 | 1.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 1.5 | 13.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.5 | 4.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 1.5 | 6.1 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.5 | 1.5 | GO:0006562 | proline catabolic process(GO:0006562) |
| 1.5 | 3.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
| 1.5 | 3.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.5 | 3.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 1.5 | 6.0 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 1.5 | 4.5 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 1.5 | 7.5 | GO:0010813 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.5 | 4.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.5 | 4.5 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 1.5 | 22.4 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 1.5 | 4.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.5 | 11.9 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.5 | 20.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 1.5 | 1.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 1.5 | 5.9 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
| 1.5 | 11.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 1.5 | 2.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 1.5 | 1.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 1.5 | 4.4 | GO:0010193 | response to ozone(GO:0010193) |
| 1.5 | 2.9 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 1.4 | 10.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 1.4 | 11.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 1.4 | 1.4 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 1.4 | 4.3 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 1.4 | 7.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 1.4 | 12.9 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.4 | 11.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 1.4 | 4.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 1.4 | 1.4 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 1.4 | 2.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 1.4 | 12.8 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.4 | 1.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 1.4 | 10.0 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 1.4 | 11.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 1.4 | 5.6 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 1.4 | 28.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 1.4 | 5.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.4 | 7.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 1.4 | 5.6 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 1.4 | 4.2 | GO:0042701 | progesterone secretion(GO:0042701) |
| 1.4 | 5.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.4 | 8.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 1.4 | 11.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 1.4 | 4.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 1.4 | 2.8 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
| 1.4 | 2.8 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 1.4 | 13.8 | GO:0051593 | response to folic acid(GO:0051593) |
| 1.4 | 1.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.4 | 1.4 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 1.4 | 10.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.4 | 16.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 1.4 | 1.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 1.4 | 4.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.4 | 1.4 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 1.4 | 5.4 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 1.4 | 21.6 | GO:0015671 | oxygen transport(GO:0015671) |
| 1.3 | 1.3 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 1.3 | 1.3 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 1.3 | 4.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 1.3 | 12.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 1.3 | 9.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 1.3 | 2.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 1.3 | 4.0 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.3 | 2.7 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 1.3 | 1.3 | GO:0015847 | putrescine transport(GO:0015847) |
| 1.3 | 18.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 1.3 | 2.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 1.3 | 15.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 1.3 | 4.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.3 | 2.6 | GO:0009750 | response to fructose(GO:0009750) |
| 1.3 | 3.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.3 | 10.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 1.3 | 1.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 1.3 | 20.9 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 1.3 | 7.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 1.3 | 5.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.3 | 31.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 1.3 | 6.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 1.3 | 5.2 | GO:0032988 | ribosome disassembly(GO:0032790) ribonucleoprotein complex disassembly(GO:0032988) |
| 1.3 | 2.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 1.3 | 3.9 | GO:0060023 | soft palate development(GO:0060023) |
| 1.3 | 2.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.3 | 5.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 1.3 | 10.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 1.3 | 7.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 1.3 | 3.8 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 1.3 | 1.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 1.3 | 9.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 1.3 | 5.1 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
| 1.3 | 2.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 1.3 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 1.3 | 1.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 1.3 | 5.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.3 | 5.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 1.2 | 1.2 | GO:0035106 | operant conditioning(GO:0035106) |
| 1.2 | 10.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.2 | 2.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.2 | 7.5 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 1.2 | 3.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.2 | 2.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 1.2 | 22.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 1.2 | 1.2 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 1.2 | 12.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 1.2 | 4.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.2 | 3.7 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 1.2 | 6.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 1.2 | 7.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 1.2 | 31.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 1.2 | 12.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 1.2 | 14.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.2 | 1.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.2 | 7.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.2 | 2.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 1.2 | 3.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.2 | 6.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.2 | 4.8 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 1.2 | 2.4 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.2 | 10.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 1.2 | 4.8 | GO:0090009 | primitive streak formation(GO:0090009) |
| 1.2 | 8.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 1.2 | 2.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 1.2 | 11.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.2 | 8.3 | GO:0009299 | mRNA transcription(GO:0009299) |
| 1.2 | 4.7 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.2 | 1.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 1.2 | 2.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
| 1.2 | 9.4 | GO:0097186 | amelogenesis(GO:0097186) |
| 1.2 | 36.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 1.2 | 4.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 1.2 | 12.9 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 1.2 | 22.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 1.2 | 3.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.2 | 4.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.2 | 9.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.2 | 11.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.2 | 23.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 1.2 | 9.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.2 | 5.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.2 | 7.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 1.2 | 1.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 1.2 | 6.9 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 1.1 | 4.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 1.1 | 28.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 1.1 | 2.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 1.1 | 3.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.1 | 4.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 1.1 | 1.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 1.1 | 5.7 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 1.1 | 1.1 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 1.1 | 4.6 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 1.1 | 1.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 1.1 | 17.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 1.1 | 3.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.1 | 3.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 1.1 | 10.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 1.1 | 7.9 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 1.1 | 7.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 1.1 | 6.7 | GO:0015889 | cobalamin transport(GO:0015889) |
| 1.1 | 25.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 1.1 | 1.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
| 1.1 | 6.7 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 1.1 | 5.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 1.1 | 1.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.1 | 5.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.1 | 2.2 | GO:0098581 | detection of molecule of bacterial origin(GO:0032490) detection of external biotic stimulus(GO:0098581) |
| 1.1 | 3.3 | GO:0048539 | bone marrow development(GO:0048539) |
| 1.1 | 1.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.1 | 30.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 1.1 | 12.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 1.1 | 3.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 1.1 | 3.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.1 | 12.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 1.1 | 4.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 1.1 | 4.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 1.1 | 18.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 1.1 | 29.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 1.1 | 4.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 1.1 | 7.6 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
| 1.1 | 1.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 1.1 | 7.6 | GO:0042148 | strand invasion(GO:0042148) |
| 1.1 | 10.8 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 1.1 | 1.1 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 1.1 | 2.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 1.1 | 10.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.1 | 3.2 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
| 1.1 | 1.1 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.1 | 17.1 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 1.1 | 10.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 1.1 | 2.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 1.1 | 5.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 1.1 | 7.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 1.1 | 26.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 1.1 | 3.2 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
| 1.1 | 12.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 1.1 | 7.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 1.1 | 2.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 1.1 | 4.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 1.1 | 9.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 1.1 | 1.1 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 1.0 | 7.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 1.0 | 2.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 1.0 | 4.2 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
| 1.0 | 10.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.0 | 27.1 | GO:0048265 | response to pain(GO:0048265) |
| 1.0 | 4.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.0 | 4.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.0 | 8.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 1.0 | 1.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
| 1.0 | 3.1 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 1.0 | 1.0 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 1.0 | 8.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.0 | 78.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.0 | 3.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 1.0 | 1.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 1.0 | 7.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 1.0 | 26.5 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 1.0 | 8.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.0 | 7.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 1.0 | 2.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 1.0 | 14.2 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 1.0 | 5.1 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 1.0 | 10.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 1.0 | 35.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 1.0 | 1.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 1.0 | 3.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.0 | 10.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 1.0 | 8.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 1.0 | 1.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 1.0 | 2.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.0 | 3.0 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 1.0 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 1.0 | 2.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 1.0 | 2.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 1.0 | 1.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 1.0 | 2.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 1.0 | 4.9 | GO:0006116 | NADH oxidation(GO:0006116) |
| 1.0 | 46.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 1.0 | 1.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 1.0 | 15.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 1.0 | 21.7 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 1.0 | 3.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.0 | 2.0 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.0 | 2.9 | GO:1901142 | insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 1.0 | 1.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 1.0 | 5.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.0 | 11.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 1.0 | 12.6 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 1.0 | 1.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 1.0 | 4.8 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 1.0 | 5.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.0 | 1.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 1.0 | 1.0 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 1.0 | 1.9 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
| 1.0 | 5.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 1.0 | 7.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 1.0 | 3.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 1.0 | 16.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.9 | 1.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.9 | 1.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.9 | 4.7 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
| 0.9 | 16.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.9 | 3.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.9 | 6.6 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.9 | 2.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.9 | 3.8 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.9 | 5.6 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.9 | 2.8 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.9 | 0.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.9 | 3.7 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.9 | 7.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.9 | 3.7 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.9 | 8.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.9 | 1.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.9 | 4.7 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.9 | 33.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.9 | 6.5 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
| 0.9 | 0.9 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.9 | 1.9 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
| 0.9 | 2.8 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.9 | 1.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.9 | 1.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.9 | 1.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.9 | 4.6 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.9 | 2.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.9 | 4.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.9 | 2.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.9 | 8.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.9 | 12.8 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.9 | 3.6 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.9 | 2.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.9 | 1.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.9 | 3.6 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.9 | 9.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.9 | 1.8 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.9 | 29.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.9 | 5.4 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.9 | 4.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.9 | 8.9 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.9 | 6.2 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.9 | 4.4 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.9 | 5.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.9 | 5.3 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.9 | 1.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.9 | 2.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.9 | 3.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.9 | 2.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.9 | 33.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.9 | 18.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.9 | 2.6 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
| 0.9 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.9 | 1.7 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.9 | 2.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.9 | 44.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.9 | 0.9 | GO:0060061 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.9 | 3.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.9 | 4.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
| 0.9 | 2.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.9 | 1.7 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.8 | 0.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.8 | 12.7 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.8 | 1.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.8 | 5.9 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.8 | 3.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.8 | 6.7 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.8 | 30.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.8 | 23.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.8 | 0.8 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.8 | 5.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.8 | 13.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.8 | 5.8 | GO:1904431 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
| 0.8 | 15.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.8 | 3.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.8 | 19.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.8 | 0.8 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.8 | 4.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.8 | 1.6 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.8 | 1.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.8 | 22.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.8 | 0.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.8 | 21.1 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.8 | 21.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.8 | 10.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.8 | 0.8 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.8 | 8.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.8 | 10.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.8 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.8 | 1.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.8 | 2.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.8 | 2.4 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.8 | 8.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.8 | 2.4 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.8 | 11.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.8 | 0.8 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.8 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.8 | 1.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.8 | 5.5 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 0.8 | 1.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.8 | 11.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.8 | 5.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.8 | 4.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.8 | 1.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.8 | 2.3 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
| 0.8 | 8.5 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.8 | 3.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.8 | 2.3 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.8 | 2.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.8 | 0.8 | GO:0045072 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 0.8 | 1.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.8 | 7.6 | GO:0048538 | thymus development(GO:0048538) |
| 0.8 | 3.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
| 0.8 | 0.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.8 | 0.8 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.8 | 3.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.8 | 3.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.7 | 5.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.7 | 2.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.7 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 | 0.7 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.7 | 2.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.7 | 1.5 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.7 | 3.0 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.7 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.7 | 8.2 | GO:0097009 | energy homeostasis(GO:0097009) |
| 0.7 | 0.7 | GO:0021767 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
| 0.7 | 7.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.7 | 2.2 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.7 | 13.1 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.7 | 5.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.7 | 10.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.7 | 2.2 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.7 | 6.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.7 | 11.5 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
| 0.7 | 7.2 | GO:0042311 | vasodilation(GO:0042311) |
| 0.7 | 2.2 | GO:0010224 | response to UV-B(GO:0010224) |
| 0.7 | 2.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.7 | 1.4 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
| 0.7 | 2.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.7 | 5.0 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.7 | 0.7 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.7 | 0.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.7 | 10.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.7 | 5.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.7 | 5.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.7 | 24.1 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
| 0.7 | 12.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.7 | 5.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.7 | 1.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.7 | 2.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 0.7 | 1.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 | 2.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.7 | 3.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.7 | 1.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.7 | 2.8 | GO:0038001 | paracrine signaling(GO:0038001) |
| 0.7 | 2.1 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.7 | 2.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.7 | 4.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.7 | 0.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.7 | 1.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.7 | 7.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.7 | 2.7 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.7 | 1.4 | GO:0050717 | positive regulation of interleukin-1 alpha production(GO:0032730) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.7 | 4.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.7 | 0.7 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.7 | 4.1 | GO:0033198 | response to ATP(GO:0033198) |
| 0.7 | 0.7 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 0.7 | 2.7 | GO:0007320 | insemination(GO:0007320) |
| 0.7 | 4.1 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.7 | 16.9 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.7 | 2.0 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.7 | 3.4 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.7 | 15.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.7 | 2.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.7 | 3.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.7 | 0.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.7 | 2.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 | 2.0 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 0.7 | 1.3 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
| 0.7 | 1.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.7 | 2.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.7 | 2.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.7 | 0.7 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
| 0.7 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.7 | 4.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.6 | 5.2 | GO:0048536 | spleen development(GO:0048536) |
| 0.6 | 3.9 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.6 | 3.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.6 | 1.9 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.6 | 1.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.6 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.6 | 4.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.6 | 5.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.6 | 2.5 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.6 | 4.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.6 | 8.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.6 | 32.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.6 | 1.9 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.6 | 1.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.6 | 2.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.6 | 2.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.6 | 2.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.6 | 3.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.6 | 0.6 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 0.6 | 1.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.6 | 3.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.6 | 2.5 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.6 | 1.9 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.6 | 1.2 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.6 | 1.2 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.6 | 1.2 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.6 | 1.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.6 | 4.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.6 | 0.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.6 | 1.2 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.6 | 2.4 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.6 | 2.4 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.6 | 3.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.6 | 3.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.6 | 6.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.6 | 0.6 | GO:0060438 | trachea development(GO:0060438) |
| 0.6 | 4.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.6 | 1.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.6 | 8.4 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.6 | 4.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.6 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.6 | 3.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.6 | 3.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.6 | 4.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.6 | 17.9 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.6 | 4.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.6 | 5.4 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.6 | 27.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.6 | 2.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.6 | 3.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.6 | 1.8 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.6 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.6 | 2.4 | GO:0043201 | response to leucine(GO:0043201) |
| 0.6 | 1.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.6 | 2.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.6 | 4.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 2.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.6 | 0.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.6 | 0.6 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.6 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.6 | 2.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.6 | 8.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.6 | 5.8 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.6 | 51.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.6 | 11.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.6 | 6.4 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.6 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
| 0.6 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.6 | 1.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.6 | 0.6 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.6 | 10.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.6 | 2.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.6 | 5.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.6 | 1.7 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
| 0.6 | 0.6 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.6 | 14.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.6 | 8.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.6 | 6.8 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.6 | 1.7 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.6 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.6 | 5.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.6 | 1.1 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.6 | 4.4 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.6 | 4.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.6 | 1.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.5 | 2.2 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.5 | 1.6 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
| 0.5 | 2.7 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.5 | 3.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 2.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.5 | 2.7 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.5 | 3.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 | 0.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.5 | 2.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.5 | 1.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.5 | 1.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.5 | 1.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.5 | 1.1 | GO:0072114 | regulation of pronephros size(GO:0035565) pronephros morphogenesis(GO:0072114) |
| 0.5 | 0.5 | GO:0032645 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
| 0.5 | 5.4 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.5 | 19.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.5 | 308.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.5 | 5.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
| 0.5 | 1.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.5 | 1.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.5 | 0.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.5 | 0.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.5 | 1.0 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.5 | 3.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.5 | 4.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.5 | 1.0 | GO:0034226 | nitric oxide production involved in inflammatory response(GO:0002537) lysine transport(GO:0015819) lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transport(GO:1902022) L-lysine import into cell(GO:1903410) |
| 0.5 | 10.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.5 | 1.5 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.5 | 7.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 | 0.5 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.5 | 6.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.5 | 1.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.5 | 0.5 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.5 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.5 | 2.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.5 | 3.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.5 | 3.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.5 | 1.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.5 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 | 8.2 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.5 | 0.5 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.5 | 7.2 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.5 | 1.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.5 | 9.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.5 | 5.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.5 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
| 0.5 | 7.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.5 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
| 0.5 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.5 | 4.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 | 0.9 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.5 | 5.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.5 | 13.4 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.5 | 3.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.5 | 13.3 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.5 | 2.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.5 | 2.7 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.5 | 0.5 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.5 | 14.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.5 | 2.3 | GO:0003341 | cilium movement(GO:0003341) |
| 0.5 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 | 7.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.5 | 16.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.5 | 1.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.4 | 0.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.4 | 1.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.4 | 5.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.4 | 1.7 | GO:0030238 | male sex determination(GO:0030238) |
| 0.4 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 | 1.7 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.4 | 1.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.4 | 0.9 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.4 | 3.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.4 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.4 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.4 | 3.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 | 2.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.4 | 2.9 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
| 0.4 | 3.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.4 | 6.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.4 | 0.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.4 | 2.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.4 | 7.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.4 | 1.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
| 0.4 | 1.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.4 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.4 | 1.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 | 0.8 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
| 0.4 | 2.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 9.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 | 3.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.4 | 1.2 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.4 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 | 3.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.4 | 3.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.4 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.4 | 1.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.4 | 0.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.4 | 2.8 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.4 | 0.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.4 | 1.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.4 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.4 | 2.0 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
| 0.4 | 2.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.4 | 2.7 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.4 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.4 | 1.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.4 | 1.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.4 | 1.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.4 | 1.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
| 0.4 | 7.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 3.7 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.4 | 1.5 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.4 | 0.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.4 | 6.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.4 | 4.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.4 | 0.4 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.4 | 1.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.4 | 0.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.4 | 1.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 0.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.4 | 0.7 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 1.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.4 | 1.8 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
| 0.4 | 3.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.3 | 1.0 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
| 0.3 | 0.3 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
| 0.3 | 2.8 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
| 0.3 | 0.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.3 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
| 0.3 | 1.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 0.3 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.3 | 2.0 | GO:0007512 | adult heart development(GO:0007512) |
| 0.3 | 0.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.3 | 26.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.3 | 1.3 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.3 | 0.7 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.3 | 2.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.3 | 7.6 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.3 | 1.0 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.3 | 0.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.3 | 1.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.3 | 1.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.3 | 1.6 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.3 | 1.0 | GO:0036233 | glycine import(GO:0036233) |
| 0.3 | 9.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.3 | 3.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.3 | 0.6 | GO:1900272 | negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.3 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 | 6.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.3 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.3 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 3.1 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.3 | 2.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.3 | 2.2 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.3 | 0.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 | 0.3 | GO:0034695 | response to prostaglandin E(GO:0034695) |
| 0.3 | 13.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.3 | 2.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 | 0.6 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.3 | 1.5 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
| 0.3 | 3.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.3 | 0.6 | GO:0046113 | xanthine metabolic process(GO:0046110) nucleobase catabolic process(GO:0046113) |
| 0.3 | 0.9 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.3 | 3.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.3 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.3 | 0.3 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.3 | 0.9 | GO:0003097 | renal water transport(GO:0003097) |
| 0.3 | 4.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.3 | 0.9 | GO:0043307 | eosinophil activation(GO:0043307) |
| 0.3 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 0.6 | GO:0021593 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
| 0.3 | 4.4 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.3 | 0.5 | GO:0048483 | autonomic nervous system development(GO:0048483) |
| 0.3 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 2.4 | GO:0031034 | myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) |
| 0.3 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.3 | 0.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.3 | 2.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.3 | 2.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.3 | 1.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.3 | 0.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.3 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.3 | 5.8 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.3 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
| 0.3 | 1.8 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.3 | 1.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.3 | 0.5 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.3 | 6.1 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.3 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.3 | 2.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.3 | 2.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
| 0.3 | 0.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.2 | 3.0 | GO:0021988 | olfactory lobe development(GO:0021988) |
| 0.2 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 0.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 2.0 | GO:0007135 | meiosis II(GO:0007135) |
| 0.2 | 2.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.2 | 2.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
| 0.2 | 0.7 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
| 0.2 | 1.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 0.5 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
| 0.2 | 0.5 | GO:0071362 | cellular response to ether(GO:0071362) |
| 0.2 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 | 1.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 32.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 | 2.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.2 | 0.7 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.2 | 0.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.2 | 5.1 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.2 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 | 0.9 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.2 | 1.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 | 33.2 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.2 | 1.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.2 | 0.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.2 | 3.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.2 | 0.4 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 | 0.6 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.2 | 3.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 0.2 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.2 | 0.4 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.2 | 2.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.2 | 0.8 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.2 | 0.8 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 | 2.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.2 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 0.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.2 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 0.4 | GO:0001554 | luteolysis(GO:0001554) |
| 0.2 | 1.1 | GO:0007140 | male meiosis(GO:0007140) |
| 0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 1.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.2 | 0.5 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.2 | 0.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.2 | 0.5 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.2 | 0.5 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 0.5 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.2 | 0.3 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 0.2 | 2.3 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.2 | 0.6 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
| 0.1 | 1.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 44.1 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.1 | 3.7 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
| 0.1 | 1.2 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 1.2 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.1 | 1.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.1 | 0.6 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 0.3 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 2.5 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
| 0.1 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.1 | 0.2 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
| 0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.1 | 1.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.1 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.1 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 | 1.0 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.1 | 0.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 2.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
| 0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 0.3 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.1 | 0.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 2.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
| 0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.5 | GO:0070076 | histone lysine demethylation(GO:0070076) |
| 0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.1 | 1.5 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
| 0.1 | 2.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.1 | 1.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.2 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.1 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 0.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 0.1 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.1 | 0.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 | 0.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.1 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 0.2 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.1 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.1 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.0 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
| 0.0 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.1 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.0 | 0.1 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.0 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.0 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.0 | 3.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.0 | 0.1 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
| 0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.0 | 0.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.0 | 35.9 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 11.8 | 35.4 | GO:0043293 | apoptosome(GO:0043293) |
| 10.5 | 31.4 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 9.7 | 29.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 9.4 | 65.7 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 7.7 | 23.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 7.6 | 22.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 7.5 | 7.5 | GO:0044308 | axonal spine(GO:0044308) |
| 7.3 | 36.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 6.7 | 26.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 6.6 | 72.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 6.6 | 26.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 6.3 | 25.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 6.1 | 30.6 | GO:0036398 | TCR signalosome(GO:0036398) |
| 6.0 | 36.0 | GO:0032010 | phagolysosome(GO:0032010) |
| 5.9 | 23.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 5.9 | 17.6 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 5.7 | 28.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 5.7 | 22.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 5.5 | 11.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 5.4 | 53.8 | GO:0044194 | cytolytic granule(GO:0044194) |
| 4.9 | 49.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 4.9 | 29.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 4.8 | 14.4 | GO:0008623 | CHRAC(GO:0008623) |
| 4.8 | 14.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 4.6 | 13.9 | GO:0000805 | X chromosome(GO:0000805) |
| 4.6 | 13.9 | GO:0097229 | sperm end piece(GO:0097229) |
| 4.6 | 27.7 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 4.6 | 55.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 4.6 | 22.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 4.4 | 35.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 4.4 | 79.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 4.4 | 30.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 4.1 | 61.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 4.1 | 4.1 | GO:0042025 | viral replication complex(GO:0019034) host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 4.0 | 44.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 4.0 | 11.9 | GO:1903349 | omegasome membrane(GO:1903349) |
| 3.9 | 74.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 3.9 | 27.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 3.9 | 43.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 3.9 | 7.8 | GO:0001939 | female pronucleus(GO:0001939) |
| 3.9 | 34.8 | GO:0071953 | elastic fiber(GO:0071953) |
| 3.7 | 18.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 3.6 | 10.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 3.6 | 10.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 3.6 | 21.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 3.6 | 10.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 3.6 | 179.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 3.6 | 3.6 | GO:0045120 | pronucleus(GO:0045120) |
| 3.6 | 14.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 3.5 | 14.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 3.5 | 66.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 3.4 | 10.3 | GO:0032426 | stereocilium tip(GO:0032426) |
| 3.4 | 13.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 3.4 | 10.1 | GO:0055028 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
| 3.4 | 10.1 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 3.3 | 19.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 3.3 | 29.6 | GO:0033391 | chromatoid body(GO:0033391) |
| 3.3 | 3.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 3.2 | 29.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 3.2 | 19.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 3.2 | 9.5 | GO:0032116 | SMC loading complex(GO:0032116) |
| 3.2 | 9.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 3.1 | 9.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 3.1 | 24.6 | GO:0000322 | storage vacuole(GO:0000322) |
| 3.1 | 6.1 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 3.0 | 8.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 3.0 | 20.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 2.9 | 43.5 | GO:0005861 | troponin complex(GO:0005861) |
| 2.9 | 14.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 2.9 | 8.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 2.9 | 25.9 | GO:0001520 | outer dense fiber(GO:0001520) |
| 2.9 | 11.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 2.8 | 11.0 | GO:0070695 | FHF complex(GO:0070695) |
| 2.7 | 13.7 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 2.7 | 13.5 | GO:0042825 | TAP complex(GO:0042825) |
| 2.7 | 21.4 | GO:0072487 | MSL complex(GO:0072487) |
| 2.7 | 29.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 2.7 | 69.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 2.6 | 10.6 | GO:1990879 | CST complex(GO:1990879) |
| 2.6 | 7.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 2.5 | 22.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 2.5 | 22.5 | GO:0032059 | bleb(GO:0032059) |
| 2.5 | 7.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 2.4 | 33.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 2.3 | 13.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 2.3 | 4.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 2.2 | 40.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 2.2 | 17.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 2.2 | 6.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 2.2 | 19.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 2.2 | 6.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.1 | 8.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 2.1 | 2.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 2.1 | 14.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 2.1 | 8.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 2.1 | 14.7 | GO:0043196 | varicosity(GO:0043196) |
| 2.1 | 8.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 2.1 | 22.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 2.1 | 2.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 2.0 | 4.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 2.0 | 12.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 2.0 | 12.3 | GO:0032584 | growth cone membrane(GO:0032584) |
| 2.0 | 10.2 | GO:0001652 | granular component(GO:0001652) |
| 2.0 | 8.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 2.0 | 4.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 2.0 | 11.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 2.0 | 11.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.9 | 31.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 1.9 | 11.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 1.9 | 17.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 1.9 | 9.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.9 | 14.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.8 | 5.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 1.8 | 19.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.8 | 10.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 1.8 | 63.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 1.7 | 8.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 1.7 | 13.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.7 | 85.6 | GO:0016235 | aggresome(GO:0016235) |
| 1.7 | 18.8 | GO:0032039 | integrator complex(GO:0032039) |
| 1.7 | 15.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.7 | 5.1 | GO:0034657 | GID complex(GO:0034657) |
| 1.7 | 11.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 1.7 | 11.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 1.7 | 10.0 | GO:0014802 | terminal cisterna(GO:0014802) |
| 1.7 | 3.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.6 | 4.9 | GO:0000125 | PCAF complex(GO:0000125) |
| 1.6 | 34.4 | GO:0031932 | TORC2 complex(GO:0031932) |
| 1.6 | 22.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 1.6 | 16.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 1.6 | 9.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 1.6 | 6.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 1.6 | 7.8 | GO:0071565 | nBAF complex(GO:0071565) |
| 1.6 | 9.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 1.5 | 1.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 1.5 | 18.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 1.5 | 4.6 | GO:0070876 | SOSS complex(GO:0070876) |
| 1.5 | 4.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.5 | 6.0 | GO:0090543 | Flemming body(GO:0090543) |
| 1.5 | 193.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 1.5 | 6.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 1.5 | 7.5 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 1.5 | 5.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 1.5 | 14.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 1.5 | 29.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 1.5 | 2.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.4 | 95.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 1.4 | 8.6 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.4 | 5.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.4 | 5.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.4 | 25.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 1.4 | 16.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 1.4 | 15.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.4 | 8.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 1.4 | 15.2 | GO:0097413 | Lewy body(GO:0097413) |
| 1.4 | 5.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 1.4 | 145.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 1.4 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.4 | 4.1 | GO:0060987 | lipid tube(GO:0060987) |
| 1.3 | 17.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 1.3 | 50.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 1.3 | 16.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 1.3 | 11.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 1.3 | 11.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.3 | 5.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 1.3 | 16.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 1.3 | 3.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 1.3 | 3.8 | GO:0070701 | mucus layer(GO:0070701) |
| 1.3 | 2.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.3 | 2.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 1.2 | 3.7 | GO:0097179 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) protease inhibitor complex(GO:0097179) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 1.2 | 3.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 1.2 | 8.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.2 | 1.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.2 | 8.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 1.2 | 7.0 | GO:0032009 | early phagosome(GO:0032009) |
| 1.2 | 7.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.2 | 8.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 1.1 | 4.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 1.1 | 17.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 1.1 | 159.5 | GO:0016605 | PML body(GO:0016605) |
| 1.1 | 5.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.1 | 3.2 | GO:0098536 | deuterosome(GO:0098536) |
| 1.1 | 7.6 | GO:1990745 | EARP complex(GO:1990745) |
| 1.1 | 1.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 1.1 | 13.9 | GO:0000786 | nucleosome(GO:0000786) |
| 1.1 | 7.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.1 | 6.4 | GO:0005827 | polar microtubule(GO:0005827) |
| 1.1 | 31.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 1.1 | 13.7 | GO:0042599 | lamellar body(GO:0042599) |
| 1.1 | 9.5 | GO:0030914 | STAGA complex(GO:0030914) |
| 1.0 | 4.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 1.0 | 2.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 1.0 | 10.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 1.0 | 3.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 1.0 | 1.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 1.0 | 3.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 1.0 | 19.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 1.0 | 4.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 1.0 | 9.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 1.0 | 25.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 1.0 | 18.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 1.0 | 4.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 1.0 | 20.3 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 1.0 | 2.9 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.0 | 3.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 1.0 | 12.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 1.0 | 22.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 1.0 | 2.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 1.0 | 10.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.9 | 2.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.9 | 13.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.9 | 3.6 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.9 | 5.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.9 | 35.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.9 | 10.9 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.9 | 4.5 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.9 | 6.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.9 | 1.8 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.9 | 36.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.9 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.9 | 22.1 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.9 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
| 0.9 | 8.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.9 | 14.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.9 | 16.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.9 | 26.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.8 | 5.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.8 | 4.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.8 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.8 | 15.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.8 | 11.4 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.8 | 12.8 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.8 | 6.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.8 | 2.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.8 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.8 | 12.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.8 | 1.5 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.8 | 21.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.8 | 1.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.8 | 28.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.7 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.7 | 12.4 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.7 | 11.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.7 | 5.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.7 | 43.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.7 | 2.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.7 | 11.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.7 | 6.3 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.7 | 2.8 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.7 | 2.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.7 | 3.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.7 | 4.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.7 | 8.2 | GO:0001741 | XY body(GO:0001741) |
| 0.7 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.7 | 2.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.7 | 8.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.7 | 42.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.7 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.7 | 47.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.7 | 20.9 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.7 | 2.6 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.7 | 5.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.6 | 3.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.6 | 46.5 | GO:0005814 | centriole(GO:0005814) |
| 0.6 | 2.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.6 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.6 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.6 | 2.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.6 | 8.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 3.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.6 | 4.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.6 | 5.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.6 | 4.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.6 | 6.8 | GO:0000800 | lateral element(GO:0000800) |
| 0.6 | 1.9 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.6 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.6 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.6 | 0.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.6 | 3.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.6 | 0.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.6 | 3.0 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.6 | 11.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.6 | 0.6 | GO:0030120 | vesicle coat(GO:0030120) |
| 0.6 | 4.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.6 | 4.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.6 | 2.3 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.6 | 2.9 | GO:0005638 | lamin filament(GO:0005638) |
| 0.6 | 213.6 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.6 | 48.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.6 | 7.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.6 | 36.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.6 | 13.4 | GO:0097546 | ciliary base(GO:0097546) |
| 0.6 | 2.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.5 | 2.7 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.5 | 75.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.5 | 11.7 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.5 | 6.9 | GO:0030478 | actin cap(GO:0030478) |
| 0.5 | 7.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.5 | 1.6 | GO:0031251 | PAN complex(GO:0031251) |
| 0.5 | 70.0 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.5 | 2.1 | GO:0002177 | manchette(GO:0002177) |
| 0.5 | 1.6 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.5 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.5 | 13.7 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.5 | 25.7 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.5 | 7.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.5 | 61.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.5 | 33.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.5 | 13.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.5 | 1.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.5 | 4.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.5 | 2.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.5 | 1.4 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.5 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
| 0.5 | 32.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.5 | 0.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.5 | 5.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.5 | 170.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.5 | 46.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.5 | 7.7 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.4 | 2.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.4 | 1.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.4 | 1.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.4 | 1.8 | GO:0032449 | CBM complex(GO:0032449) |
| 0.4 | 3.9 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.4 | 1.7 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.4 | 10.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.4 | 7.7 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 8.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 1.3 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.4 | 28.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.4 | 2.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.4 | 25.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.4 | 9.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.4 | 20.5 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.4 | 7.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.4 | 76.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.4 | 16.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.4 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.3 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 16.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.3 | 4.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.3 | 1.0 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 2.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.3 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 8.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 3.4 | GO:0071437 | invadopodium(GO:0071437) |
| 0.3 | 1.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.3 | 4.4 | GO:0042627 | chylomicron(GO:0042627) |
| 0.3 | 0.3 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.3 | 1.0 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.3 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.3 | 11.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 5.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.3 | 14.4 | GO:0016459 | myosin complex(GO:0016459) |
| 0.3 | 1.2 | GO:0035363 | histone locus body(GO:0035363) |
| 0.3 | 1.5 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.3 | 6.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.3 | 2.6 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 1.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.3 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.3 | 0.8 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.3 | 7.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.3 | 3.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 166.1 | GO:0016604 | nuclear body(GO:0016604) |
| 0.2 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 0.2 | GO:0097433 | dense body(GO:0097433) |
| 0.2 | 4.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.2 | 4.3 | GO:0034703 | cation channel complex(GO:0034703) |
| 0.2 | 3.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.2 | 0.5 | GO:0038201 | TOR complex(GO:0038201) |
| 0.2 | 13.2 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 6.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.2 | 1.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 3.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 1.2 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 1.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 3.6 | GO:0008305 | integrin complex(GO:0008305) |
| 0.2 | 5.9 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 22.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.2 | 1.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 76.0 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.2 | 15.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.2 | 1.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.2 | 6.8 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 1.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 22.7 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 0.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 14.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.4 | GO:0033167 | ARC complex(GO:0033167) |
| 0.1 | 0.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 1.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 32.0 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 345.3 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.1 | 0.3 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.2 | GO:0098831 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 0.1 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 10.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 7.7 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
| 0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.0 | 2.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 2.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.0 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 20.4 | 61.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 13.2 | 52.9 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 12.0 | 47.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 11.9 | 47.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 10.5 | 52.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 10.4 | 31.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 10.2 | 30.5 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 9.9 | 39.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 8.5 | 34.1 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 8.4 | 67.5 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 8.2 | 41.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 8.0 | 31.9 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 7.9 | 31.8 | GO:0032567 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 7.6 | 30.5 | GO:0001007 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 7.4 | 22.3 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 7.4 | 29.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 7.1 | 35.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 7.1 | 42.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 7.0 | 20.9 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 7.0 | 20.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 6.7 | 40.4 | GO:0046979 | TAP2 binding(GO:0046979) |
| 6.7 | 140.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 6.6 | 19.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 6.5 | 26.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 6.4 | 38.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 6.3 | 56.9 | GO:0043426 | MRF binding(GO:0043426) |
| 6.3 | 25.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 6.0 | 42.0 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 6.0 | 41.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 6.0 | 17.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 5.9 | 35.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 5.9 | 23.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 5.8 | 23.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 5.8 | 17.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 5.8 | 80.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 5.7 | 23.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 5.7 | 22.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 5.7 | 17.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 5.6 | 5.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 5.6 | 22.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 5.6 | 27.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 5.5 | 27.7 | GO:0004803 | transposase activity(GO:0004803) |
| 5.5 | 22.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 5.4 | 27.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 5.4 | 5.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 5.3 | 15.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 5.2 | 31.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 5.1 | 40.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 5.0 | 29.9 | GO:0039552 | RIG-I binding(GO:0039552) |
| 5.0 | 5.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 5.0 | 69.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 5.0 | 14.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 4.9 | 14.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 4.9 | 4.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 4.9 | 24.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 4.9 | 19.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 4.8 | 14.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 4.7 | 14.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 4.7 | 18.8 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 4.6 | 46.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 4.6 | 13.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 4.6 | 13.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 4.5 | 18.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 4.5 | 27.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 4.5 | 81.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 4.5 | 13.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 4.5 | 13.4 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 4.5 | 246.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 4.5 | 26.8 | GO:0030172 | troponin C binding(GO:0030172) |
| 4.5 | 17.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 4.5 | 8.9 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 4.4 | 31.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 4.4 | 52.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 4.3 | 4.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 4.2 | 16.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 4.2 | 33.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 4.1 | 8.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 4.1 | 12.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 4.1 | 12.2 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 4.1 | 20.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 4.1 | 24.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 4.0 | 28.1 | GO:0005497 | androgen binding(GO:0005497) |
| 4.0 | 23.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 4.0 | 23.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 3.9 | 11.8 | GO:0061697 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 3.9 | 23.5 | GO:0031013 | troponin I binding(GO:0031013) |
| 3.8 | 23.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 3.8 | 34.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 3.7 | 18.7 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 3.7 | 48.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 3.7 | 7.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 3.7 | 48.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 3.7 | 11.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 3.7 | 11.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 3.6 | 10.9 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 3.6 | 10.9 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 3.6 | 10.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 3.6 | 14.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 3.6 | 10.9 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 3.6 | 28.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 3.6 | 10.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 3.6 | 49.8 | GO:0045159 | myosin II binding(GO:0045159) |
| 3.5 | 21.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 3.5 | 7.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 3.5 | 48.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 3.4 | 34.4 | GO:0031014 | troponin T binding(GO:0031014) |
| 3.4 | 20.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 3.4 | 20.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 3.4 | 30.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 3.3 | 10.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 3.3 | 6.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 3.3 | 13.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 3.3 | 9.8 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 3.3 | 39.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 3.2 | 12.9 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 3.2 | 12.8 | GO:0035939 | microsatellite binding(GO:0035939) |
| 3.2 | 35.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 3.2 | 3.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 3.1 | 25.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 3.1 | 15.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 3.1 | 21.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 3.1 | 34.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 3.1 | 3.1 | GO:0035326 | enhancer binding(GO:0035326) |
| 3.1 | 15.5 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 3.1 | 24.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 3.1 | 9.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 3.1 | 9.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 3.0 | 12.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 3.0 | 9.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 3.0 | 18.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 3.0 | 30.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 3.0 | 21.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 3.0 | 11.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.9 | 14.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 2.9 | 11.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 2.9 | 8.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 2.9 | 14.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) lysophosphatidic acid receptor activity(GO:0070915) |
| 2.9 | 8.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 2.8 | 14.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 2.8 | 48.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 2.8 | 22.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 2.8 | 44.7 | GO:0015923 | mannosidase activity(GO:0015923) |
| 2.8 | 19.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 2.8 | 36.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 2.8 | 41.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 2.7 | 10.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 2.7 | 5.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 2.7 | 60.0 | GO:0030275 | LRR domain binding(GO:0030275) |
| 2.7 | 40.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 2.7 | 13.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 2.7 | 8.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 2.6 | 10.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 2.6 | 31.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 2.6 | 10.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 2.6 | 12.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 2.6 | 7.7 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 2.5 | 12.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 2.5 | 12.7 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 2.5 | 10.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 2.5 | 10.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 2.5 | 17.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.5 | 42.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 2.5 | 67.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 2.5 | 7.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 2.5 | 27.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 2.5 | 7.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 2.5 | 22.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 2.4 | 4.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 2.4 | 9.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 2.4 | 7.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 2.4 | 24.1 | GO:0015925 | galactosidase activity(GO:0015925) |
| 2.4 | 19.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 2.4 | 7.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 2.4 | 9.6 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 2.4 | 11.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 2.4 | 23.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 2.4 | 21.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 2.4 | 16.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 2.4 | 16.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 2.4 | 7.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 2.3 | 9.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 2.3 | 11.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 2.3 | 30.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 2.3 | 32.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 2.3 | 2.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 2.3 | 9.3 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 2.3 | 9.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 2.3 | 9.2 | GO:0004802 | transketolase activity(GO:0004802) |
| 2.3 | 11.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 2.3 | 27.5 | GO:0015926 | glucosidase activity(GO:0015926) |
| 2.3 | 11.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 2.3 | 18.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 2.3 | 9.1 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 2.3 | 11.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 2.2 | 11.2 | GO:0034648 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 2.2 | 15.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 2.2 | 15.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 2.2 | 2.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 2.2 | 20.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 2.2 | 17.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 2.2 | 6.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 2.2 | 2.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 2.2 | 120.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 2.1 | 68.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 2.1 | 36.4 | GO:0005112 | Notch binding(GO:0005112) |
| 2.1 | 8.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 2.1 | 6.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 2.1 | 10.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 2.1 | 6.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 2.1 | 6.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 2.1 | 14.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 2.1 | 29.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 2.1 | 14.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 2.1 | 6.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 2.1 | 6.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 2.1 | 16.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 2.1 | 16.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 2.0 | 4.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 2.0 | 51.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 2.0 | 16.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 2.0 | 32.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 2.0 | 32.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 2.0 | 6.0 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 2.0 | 20.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 2.0 | 8.0 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 2.0 | 30.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 2.0 | 16.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 2.0 | 13.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 2.0 | 2.0 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 2.0 | 17.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 2.0 | 13.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 2.0 | 9.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 2.0 | 3.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 2.0 | 25.5 | GO:0019864 | IgG binding(GO:0019864) |
| 1.9 | 11.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 1.9 | 21.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 1.9 | 7.7 | GO:0016972 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 1.9 | 1.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 1.9 | 15.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.9 | 36.5 | GO:0048185 | activin binding(GO:0048185) |
| 1.9 | 7.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 1.9 | 1.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 1.9 | 11.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 1.9 | 5.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 1.9 | 15.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 1.9 | 9.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.9 | 20.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.9 | 5.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 1.9 | 14.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.8 | 5.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.8 | 7.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 1.8 | 3.7 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 1.8 | 5.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 1.8 | 3.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.8 | 18.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 1.8 | 21.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 1.8 | 7.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.8 | 10.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 1.8 | 1.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.8 | 3.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.7 | 5.2 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.7 | 24.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 1.7 | 18.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 1.7 | 3.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 1.7 | 42.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 1.7 | 5.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.7 | 5.0 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 1.7 | 50.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 1.7 | 3.4 | GO:0070888 | E-box binding(GO:0070888) |
| 1.7 | 15.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.7 | 14.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 1.6 | 4.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.6 | 24.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 1.6 | 16.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 1.6 | 32.0 | GO:0005522 | profilin binding(GO:0005522) |
| 1.6 | 4.8 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.6 | 6.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 1.6 | 28.6 | GO:0070513 | death domain binding(GO:0070513) |
| 1.6 | 7.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.6 | 4.7 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.6 | 25.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 1.6 | 57.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 1.6 | 29.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 1.5 | 9.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.5 | 1.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 1.5 | 6.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.5 | 4.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.5 | 52.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 1.5 | 4.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 1.5 | 13.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.5 | 4.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 1.5 | 6.0 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 1.5 | 4.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.5 | 7.5 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.5 | 26.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 1.5 | 17.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 1.5 | 13.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 1.5 | 13.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 1.5 | 11.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 1.4 | 11.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.4 | 15.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 1.4 | 2.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.4 | 4.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.4 | 8.6 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 1.4 | 8.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.4 | 1.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 1.4 | 43.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 1.4 | 14.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 1.4 | 43.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 1.4 | 16.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 1.4 | 2.8 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.4 | 9.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 1.4 | 12.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 1.4 | 1.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 1.4 | 1.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 1.4 | 5.5 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 1.4 | 10.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 1.4 | 72.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 1.4 | 6.8 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.4 | 17.6 | GO:0038191 | neuropilin binding(GO:0038191) |
| 1.4 | 5.4 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 1.3 | 4.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.3 | 8.0 | GO:0043199 | sulfate binding(GO:0043199) |
| 1.3 | 72.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 1.3 | 20.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 1.3 | 1.3 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 1.3 | 5.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 1.3 | 39.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 1.3 | 4.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.3 | 5.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.3 | 40.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 1.3 | 6.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.3 | 6.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 1.3 | 24.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 1.3 | 24.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 1.3 | 3.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 1.3 | 5.1 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 1.3 | 11.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 1.3 | 35.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 1.3 | 20.3 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.3 | 7.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 1.3 | 22.7 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 1.3 | 31.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.3 | 5.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 1.3 | 8.8 | GO:0000150 | recombinase activity(GO:0000150) |
| 1.3 | 2.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 1.2 | 3.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 1.2 | 38.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 1.2 | 8.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 1.2 | 12.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 1.2 | 6.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 1.2 | 15.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 1.2 | 2.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 1.2 | 3.6 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 1.2 | 8.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 1.2 | 7.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 1.2 | 5.9 | GO:0019956 | chemokine binding(GO:0019956) |
| 1.2 | 54.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 1.2 | 11.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 1.2 | 1.2 | GO:0034618 | arginine binding(GO:0034618) |
| 1.2 | 8.2 | GO:0019863 | IgE binding(GO:0019863) |
| 1.2 | 44.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 1.2 | 26.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 1.2 | 79.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 1.2 | 5.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 1.2 | 5.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 1.2 | 4.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 1.1 | 10.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 1.1 | 326.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 1.1 | 3.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.1 | 23.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 1.1 | 33.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 1.1 | 16.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.1 | 57.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 1.1 | 8.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 1.1 | 17.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 1.1 | 6.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 1.1 | 358.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 1.1 | 4.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 1.1 | 1.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 1.1 | 3.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 1.1 | 9.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 1.1 | 7.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 1.1 | 3.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 1.1 | 3.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 1.1 | 10.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 1.1 | 18.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 1.1 | 3.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 1.1 | 7.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 1.0 | 4.2 | GO:0031433 | telethonin binding(GO:0031433) |
| 1.0 | 17.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 1.0 | 10.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 1.0 | 6.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.0 | 4.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 1.0 | 6.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.0 | 17.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 1.0 | 407.1 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 1.0 | 7.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 1.0 | 3.1 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 1.0 | 19.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 1.0 | 2.0 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 1.0 | 3.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 1.0 | 2.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 1.0 | 10.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 1.0 | 3.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.0 | 3.0 | GO:0052725 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 1.0 | 10.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 1.0 | 3.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.0 | 7.8 | GO:1990405 | protein antigen binding(GO:1990405) |
| 1.0 | 5.9 | GO:0051425 | PTB domain binding(GO:0051425) |
| 1.0 | 2.9 | GO:0004040 | amidase activity(GO:0004040) |
| 1.0 | 3.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 1.0 | 3.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 1.0 | 2.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 1.0 | 8.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 1.0 | 1.0 | GO:0002054 | nucleobase binding(GO:0002054) |
| 1.0 | 5.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.0 | 12.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 1.0 | 1.9 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.9 | 7.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.9 | 6.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.9 | 2.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.9 | 9.4 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.9 | 2.8 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
| 0.9 | 2.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.9 | 76.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.9 | 21.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.9 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.9 | 4.5 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.9 | 236.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.9 | 19.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.9 | 5.4 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.9 | 5.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.9 | 5.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.9 | 23.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.9 | 2.6 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.9 | 2.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.9 | 3.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.9 | 3.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.9 | 14.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.9 | 2.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.9 | 5.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.9 | 2.6 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.9 | 10.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.9 | 1.7 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.8 | 24.6 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.8 | 3.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.8 | 12.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.8 | 16.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.8 | 5.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.8 | 3.3 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.8 | 2.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.8 | 10.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.8 | 2.5 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 0.8 | 291.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
| 0.8 | 6.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.8 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.8 | 7.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.8 | 10.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.8 | 29.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.8 | 10.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.8 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.8 | 4.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.8 | 2.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.8 | 2.4 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.8 | 15.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.8 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.8 | 19.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.8 | 23.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.8 | 6.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.8 | 5.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.8 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.8 | 2.3 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.8 | 1.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.7 | 32.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.7 | 3.0 | GO:0035473 | lipase binding(GO:0035473) |
| 0.7 | 0.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.7 | 16.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.7 | 11.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.7 | 5.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.7 | 2.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.7 | 3.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.7 | 2.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.7 | 4.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.7 | 6.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.7 | 8.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.7 | 1.4 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.7 | 68.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.7 | 10.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.7 | 15.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.7 | 2.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.7 | 15.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.7 | 5.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.7 | 6.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.7 | 2.0 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.7 | 43.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.7 | 2.7 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.7 | 18.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.7 | 1.3 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.7 | 2.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.7 | 5.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.7 | 2.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.7 | 4.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.7 | 2.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.7 | 3.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.7 | 3.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.6 | 10.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.6 | 0.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.6 | 3.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.6 | 3.2 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.6 | 3.8 | GO:0070728 | leucine binding(GO:0070728) |
| 0.6 | 1.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.6 | 2.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.6 | 1.9 | GO:0002046 | opsin binding(GO:0002046) |
| 0.6 | 6.2 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.6 | 4.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.6 | 1.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.6 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.6 | 12.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.6 | 4.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.6 | 3.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
| 0.6 | 47.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.6 | 9.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.6 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.6 | 7.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.6 | 3.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.6 | 4.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.6 | 2.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.6 | 6.9 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.6 | 9.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.6 | 4.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.6 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.6 | 2.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.6 | 3.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.6 | 7.9 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
| 0.6 | 2.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.6 | 22.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.6 | 3.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.5 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.5 | 3.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 0.5 | 18.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.5 | 1.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.5 | 2.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.5 | 4.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 0.5 | 2.7 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.5 | 13.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.5 | 13.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.5 | 52.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.5 | 6.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.5 | 5.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.5 | 3.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.5 | 2.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.5 | 2.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.5 | 3.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.5 | 10.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.5 | 1.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.5 | 11.2 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.5 | 15.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.5 | 1.0 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
| 0.5 | 11.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.5 | 2.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.5 | 32.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.5 | 5.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.5 | 1.9 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.5 | 4.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.5 | 5.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.5 | 38.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.5 | 3.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.5 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.5 | 4.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.5 | 3.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.5 | 2.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.5 | 21.3 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.5 | 12.7 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.5 | 3.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.5 | 0.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.5 | 1.4 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.5 | 1.4 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.5 | 17.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.5 | 2.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.5 | 3.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.5 | 1.4 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.5 | 3.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 0.9 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.4 | 16.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.4 | 1.3 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.4 | 0.9 | GO:1901338 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
| 0.4 | 4.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.4 | 199.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.4 | 1.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.4 | 2.9 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.4 | 12.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.4 | 0.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.4 | 16.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.4 | 4.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.4 | 2.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.4 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
| 0.4 | 3.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.4 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.4 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.4 | 1.5 | GO:0009975 | cyclase activity(GO:0009975) |
| 0.4 | 4.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.4 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.4 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.4 | 8.9 | GO:0015464 | acetylcholine receptor activity(GO:0015464) acetylcholine-gated cation channel activity(GO:0022848) |
| 0.4 | 7.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.4 | 0.7 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.4 | 1.8 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 1.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.4 | 2.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.4 | 0.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.4 | 7.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.4 | 1.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.4 | 8.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.4 | 3.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.4 | 2.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.4 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.4 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.4 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.4 | 3.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.3 | 6.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.3 | 3.8 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
| 0.3 | 1.7 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.3 | 20.4 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.3 | 3.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.3 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.3 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.3 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 2.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.3 | 1.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.3 | 3.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.3 | 1.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.3 | 3.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.3 | 1.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.3 | 0.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.3 | 1.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.3 | 5.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.3 | 4.1 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.3 | 2.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.3 | 3.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 15.9 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.3 | 0.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.3 | 0.9 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.3 | 8.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.3 | 0.9 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.3 | 23.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.3 | 4.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.3 | 0.3 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.3 | 7.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.3 | 2.4 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.3 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.3 | 1.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.3 | 1.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 0.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.3 | 0.8 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.3 | 1.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 3.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.3 | 1.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.3 | 1.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 7.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 4.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 7.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.2 | 1.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 1.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.2 | 13.6 | GO:0005261 | cation channel activity(GO:0005261) |
| 0.2 | 0.9 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.2 | 9.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.2 | 2.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 9.7 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
| 0.2 | 5.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 2.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 3.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 1.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.2 | 4.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 0.6 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.2 | 0.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.2 | 2.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 5.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.2 | 0.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.2 | 1.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.2 | 1.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 2.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.2 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.5 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.2 | 1.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 0.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.2 | 0.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.2 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.2 | 12.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.2 | 0.6 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.2 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 0.3 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.1 | 3.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.1 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 13.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.1 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 0.6 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.1 | 3.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 5.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.1 | 26.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.1 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.1 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 1.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.1 | 3.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.7 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.1 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.1 | 1.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.1 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.1 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
| 0.1 | 0.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 0.0 | 1.8 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 3.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.1 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.0 | 3.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.0 | 5.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 4.9 | 14.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 3.8 | 48.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 3.7 | 125.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 3.6 | 50.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 3.5 | 38.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 3.4 | 3.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 3.3 | 138.4 | PID EPO PATHWAY | EPO signaling pathway |
| 3.3 | 26.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 3.2 | 155.3 | PID RAS PATHWAY | Regulation of Ras family activation |
| 3.1 | 12.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 3.0 | 50.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 2.9 | 44.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 2.9 | 154.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 2.9 | 11.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 2.8 | 13.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 2.3 | 146.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 2.2 | 159.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 2.2 | 107.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 2.1 | 72.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 2.1 | 83.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 2.0 | 103.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 2.0 | 8.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 2.0 | 6.0 | ST GAQ PATHWAY | G alpha q Pathway |
| 1.8 | 77.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 1.8 | 27.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 1.7 | 53.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 1.7 | 83.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 1.7 | 27.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 1.7 | 37.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 1.7 | 5.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 1.7 | 5.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 1.6 | 92.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 1.5 | 69.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 1.5 | 5.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 1.4 | 11.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.4 | 13.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 1.4 | 13.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 1.4 | 20.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 1.4 | 2.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 1.3 | 20.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 1.3 | 23.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 1.3 | 2.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 1.2 | 10.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 1.2 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.2 | 37.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 1.2 | 44.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 1.2 | 58.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 1.2 | 96.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 1.2 | 14.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 1.2 | 11.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 1.2 | 11.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 1.1 | 4.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 1.1 | 26.8 | PID ALK1 PATHWAY | ALK1 signaling events |
| 1.1 | 17.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 1.1 | 30.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 1.1 | 6.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 1.0 | 49.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 1.0 | 8.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.9 | 166.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.9 | 14.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.9 | 34.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.9 | 16.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.9 | 14.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.9 | 14.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.9 | 68.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.9 | 34.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.8 | 11.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.8 | 18.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.8 | 32.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.8 | 14.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.8 | 44.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.8 | 39.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.7 | 33.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.7 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.7 | 10.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.7 | 17.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.7 | 6.0 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.6 | 1.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.6 | 28.9 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.6 | 8.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.6 | 8.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.6 | 4.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.6 | 19.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.6 | 10.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.6 | 8.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.6 | 13.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.5 | 134.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.5 | 40.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.5 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.5 | 31.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.5 | 10.1 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.5 | 20.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.5 | 10.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.5 | 15.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.5 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.5 | 28.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.5 | 90.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.4 | 4.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.4 | 1.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.4 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.4 | 5.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.4 | 15.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.4 | 27.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.4 | 3.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.4 | 108.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.4 | 13.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.4 | 6.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.4 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.3 | 5.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 3.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.3 | 4.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.3 | 13.3 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.3 | 3.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.3 | 3.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 12.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.3 | 10.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 4.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 7.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.2 | 7.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 3.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.2 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 5.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 3.0 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 2.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 11.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 2.3 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 5.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 4.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 2.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.9 | 10.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 7.4 | 36.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 6.0 | 66.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 5.3 | 5.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 5.0 | 216.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 4.7 | 4.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 4.6 | 125.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 4.5 | 72.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 4.1 | 8.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 3.7 | 63.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 3.6 | 14.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 3.5 | 48.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 3.5 | 34.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 3.1 | 6.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 3.1 | 6.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 3.0 | 21.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 3.0 | 137.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 2.9 | 44.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 2.8 | 19.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 2.8 | 89.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 2.7 | 2.7 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
| 2.6 | 34.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 2.6 | 20.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 2.5 | 35.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 2.5 | 4.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 2.4 | 12.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 2.2 | 45.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 2.2 | 4.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 2.2 | 49.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 2.1 | 25.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 2.0 | 9.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 1.9 | 38.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 1.9 | 24.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 1.9 | 97.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 1.9 | 32.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 1.9 | 5.6 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 1.8 | 3.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.8 | 47.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 1.8 | 1.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 1.8 | 12.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.7 | 12.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.7 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 1.7 | 50.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.7 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 1.6 | 144.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 1.6 | 57.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 1.6 | 80.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 1.5 | 12.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.5 | 19.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 1.5 | 4.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 1.5 | 48.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 1.5 | 10.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 1.4 | 27.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.4 | 20.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 1.4 | 34.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 1.4 | 42.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 1.4 | 24.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.4 | 23.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 1.3 | 8.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 1.3 | 25.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 1.3 | 10.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 1.3 | 2.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 1.3 | 13.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 1.3 | 16.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 1.3 | 56.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 1.3 | 34.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 1.2 | 71.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 1.2 | 26.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.2 | 98.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.2 | 73.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.2 | 12.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 1.1 | 123.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 1.1 | 14.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 1.1 | 38.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 1.0 | 92.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 1.0 | 25.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 1.0 | 36.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 1.0 | 8.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 1.0 | 6.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.9 | 22.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.9 | 10.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.9 | 1.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.9 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.9 | 87.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.9 | 0.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.9 | 28.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.9 | 27.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.9 | 55.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.9 | 2.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.8 | 18.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.8 | 59.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.8 | 21.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.8 | 8.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.8 | 28.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.8 | 8.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.8 | 64.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.8 | 33.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.8 | 23.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.7 | 3.0 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.7 | 11.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.7 | 20.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.7 | 24.9 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.7 | 23.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.7 | 6.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.7 | 6.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.7 | 114.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.7 | 43.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.7 | 33.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.7 | 13.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.7 | 11.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.7 | 15.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.7 | 4.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.6 | 15.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.6 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.6 | 4.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.6 | 6.8 | REACTOME OPSINS | Genes involved in Opsins |
| 0.6 | 13.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.6 | 4.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.6 | 4.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.6 | 5.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.6 | 80.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.6 | 23.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.5 | 7.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.5 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.5 | 8.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.5 | 4.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.5 | 48.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.5 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.5 | 2.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.5 | 4.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.5 | 15.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.5 | 9.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.5 | 1.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.5 | 9.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.5 | 99.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.5 | 3.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.4 | 7.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 38.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.4 | 3.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.4 | 12.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.4 | 2.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.4 | 13.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.4 | 2.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.4 | 24.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.4 | 7.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.4 | 10.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.4 | 8.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.4 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.4 | 7.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.4 | 7.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.4 | 4.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.3 | 7.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.3 | 3.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.3 | 4.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.3 | 5.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 4.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 5.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 13.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.3 | 4.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.3 | 3.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.3 | 10.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.3 | 5.4 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.3 | 3.7 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
| 0.3 | 40.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.3 | 11.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 2.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 3.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 1.8 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
| 0.2 | 4.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.2 | 4.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.2 | 7.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 23.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.2 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.2 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.1 | 2.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 3.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 2.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 0.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |